Technology for inclusion, layoffs, oncology approvals, and $200M for a tech platform.
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Gilead
AstraZeneca + Merck + Myriad
DNAnexus
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Listening
Episode
Tech-clusion, Gilead, AstraZeneca + Merck + Myriad, DNAnexus
The recording for this episode is no longer available from its publisher. Everything else about it is kept here.